Table 3.
MODEL 1 | ||||||
---|---|---|---|---|---|---|
B | S.E. | Wald | P | OR | 95% C.I. | |
BMQ | ||||||
Specific Necessity | −0.065 | 0.165 | 0.155 | 0.694 | 0.937 | 0.678 to 1.296 |
Specific Concern | −0.555 | 0.178 | 9.745 | 0.002 | 0.574 | 0.405 to 0.813 |
General Overuse | −0.256 | 0.181 | 1.994 | 0.158 | 0.774 | 0.543 to 1.104 |
General Harm | −0.184 | 0.180 | 1.053 | 0.305 | 0.832 | 0.585 to 1.183 |
MODEL 2 | ||||||
B | S.E. | Wald | P | OR | 95% C.I. | |
BIPQ (overall score) | −0.036 | 0.011 | 10.956 | 0.001 | 0.964 | 0.944 to 0.985 |
MODEL 3 | ||||||
B | S.E. | Wald | P | OR | 95% C.I. | |
BMQ | ||||||
Specific Necessity | −0.165 | 0.198 | 0.695 | 0.405 | 0.848 | 0.575 to 1.250 |
Specific Concern | −0.427 | 0.211 | 4.079 | 0.043 | 0.652 | 0.431 to 0.987 |
General Overuse | −0.249 | 0.219 | 1.292 | 0.256 | 0.780 | 0.508 to 1.197 |
General Harm | −0.298 | 0.219 | 1.853 | 0.173 | 0.742 | 0.484 to 1.140 |
BIPQ | ||||||
Consequences | −0.103 | 0.087 | 1.401 | 0.237 | 0.902 | 0.761 to 1.070 |
Timeline | −0.011 | 0.075 | 0.022 | 0.881 | 0.989 | 0.854 to 1.145 |
Personal control | 0.086 | 0.067 | 1.630 | 0.202 | 1.089 | 0.955 to 1.242 |
Treatment control | −0.110 | 0.086 | 1.660 | 0.198 | 0.895 | 0.757 to 1.059 |
Identity | −0.162 | 0.104 | 2.441 | 0.118 | 0.850 | 0.693 to 1.042 |
Emotional Representation (concern) | 0.040 | 0.104 | 0.148 | 0.700 | 1.041 | 0.849 to 1.277 |
Emotional Representation (emotions) | −0.025 | 0.110 | 0.051 | 0.821 | 0.975 | 0.786 to 1.210 |
Comprehensibility | −0.060 | 0.064 | 0.861 | 0.353 | 0.942 | 0.831 to 1.069 |
Notes: Model 1: Adjusted for medication belief. Model 2: Adjusted for the perception of illness (overall score) and age, sex, NIHSS, education, occupation, duration of disease, and payment methods. Model 3: Adjusted for model 1 and each of the domains of the perception of illness, and age, sex, NIHSS, education, occupation, duration of disease, and payment methods.
Abbreviations: BMQ, Beliefs about Medicines Questionnaire; BIPQ, Brief Illness Perception Questionnaire.